Analyst upgrades dominated Friday's session. Industrial and energy names led the way in target price revisions.
AMETEK saw its consensus target rise to $256.79 from $253.78. The $54 billion electronic instruments maker continues to draw bullish sentiment from Wall Street. 14 analysts currently rate the stock a Buy.
Hubbell got an even sharper lift. The consensus target jumped to $543.31 from $535.77. The electrical products company is backed by 7 Buy ratings. Its short interest sits at just 4.8% of free float, suggesting limited bearish pressure.
Ares Management also attracted fresh upside. The consensus price target moved to $142.47. With 11 Buy ratings and short interest at 6.6%, the alternative asset manager remains a firm Street favourite.
Energy names split. Occidental Petroleum earned a target bump to $63.88. Exxon Mobil saw its target trimmed slightly to $165.64.
Martin Marietta Materials received a target nudge to $692.35. The aggregates giant holds 13 Buy ratings against just one Sell.
AbbVie rounded out the upgrades. Its target moved to $250.33, supported by 23 Buy ratings. The pharma heavyweight shows broad analyst backing heading into May.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
